Gilead to Acquire Arcellx for $7.8 Billion to Expand CAR-T Therapy Portfolio
The American pharmaceutical company Gilead has announced the signing of an agreement to acquire the biotechnology company Arcellx for $7.8…
investment in biotech
The American pharmaceutical company Gilead has announced the signing of an agreement to acquire the biotechnology company Arcellx for $7.8…